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Abstract
Male infertility can be treated by surgical procedures (e.g., varicocelectomy) or by administration of
drugs if causal factors (e.g., seminal tract infections) are detected. In more severe cases, methods of
assisted fertilization often have to be applied, but even these have only a limited success rate. Recent
studies have demonstrated that disturbances of sperm DNA integrity (determined by the acridine
orange test) can explain certain cases of fertilization failure and failure to achieve pregnancy following
in vitro fertilisation with intracytoplasmic sperm injection. The evaluation of DNA integrity should be
considered when diagnosing male infertility as it has been shown to be an independent factor and can
be used as a supplement to standard semen analysis. Analysis of DNA integrity may, therefore,
provide further information about altered male fertility and lead to administration of more
appropriate therapy.
Introduction and context
DNA integrity is a prerequisite, not only for the
fertilization of an oocyte, but also for oocyte activation
and achievement of an ongoing pregnancy [1]. It has
been documented that there is a negative correlation
between defective sperm chromatin structure (DNA
breaks) and fertility, in vivo and in vitro [2]. Several
studies have demonstrated that disturbed DNA integrity
reduces fertilization and pregnancy rate during in vitro
fertilisation (IVF) and intracytoplasmic sperm injection
(ICSI) treatment, and also increases the risk of early
miscarriage [3,4].
DNA integrity can be assessed by the sperm chromatin
structure assay (SCSA), by terminal deoxynucleotidyl
transferase-mediated dUTP nick end labelling (TUNEL),
and more recently, the sperm chromatin dispersion
assay. Special consideration should be made when
comparing these methods, however, because they are
each measuring different parameters. The SCSA is
considered an indirect indicator of DNA damage. It is
based on exposing sperm nuclei to acid then staining
them with acridine orange (the acid exposure causes
denaturation of double-stranded DNA in sperm with
impaired chromatin structure). The stain will attach to
the ends of the broken DNA only, enabling evaluation
of the proportion of single- and double-stranded DNA
in the sample. The sperm chromatin dispersion assay
also measures the susceptibility of sperm DNA to acid
denaturation, but in a different way. The SCSA is based
on the metachromatic property of the stain acridine
orange, where intact DNA are characterized by a green
fluorescence and disturbed DNA by orange fluorescence.
The evaluation is carried out by flow cytometry; therefore
a high number of cells (about 10,000) can be studied.
The sperm chromatin dispersion test is performed using
conventional bright field microscopy and analyses
dispersed DNA loop halos. Between 300 and 500
spermatozoa can be evaluated during this test. The
TUNEL assay uses fluorescein-dUTP to label single- and
double-stranded DNA breaks.[5–7].
Recent advances
In most recent studies, no correlation between DNA
integrity and conventional semen parameters has been
found; therefore, DNA integrity can be considered as a
sperm function that is independent from sperm count,
motility, and morphology [7,8].
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in patients with varicoceles, testicular tumours, genital
tract infections/inflammations, and patients with ‘idio-
pathic’ infertility [1,9,10]. Disturbances of DNA integrity
occur predominatly at the post-testicular level, which is
why a recent study suggested testicular sperm extraction
with subsequent ICSI as a possible treatment [11].
Research by different groups suggests that extrinsic
oxidative stress, including environmental or industrial
toxins or smoking, seems to be the major cause of sperm
DNA damage rather than apoptosis [5], and a recentstudy
showed that treatment with antioxidants has positive
effects on implantation and pregnancy rates after
ICSI [12].
Regarding further treatment options for disturbed DNA
integrity, it is fortunate that a considerable number of
recent studies have focused on the correlation between
disturbed DNA integrity and genital tract inflammations
and infections, respectively. It was shown that DNA
integrity was impaired in leukocytospermic semen sam-
ples [13,14], and in patients with less than 1 million
leukocytes per ml and high levels of reactive oxygen
species [5]. In the last scenario, disturbed DNA integrity
may still allow oocyte fertilization and formation of the
2-pronuclei stage, but when the paternal genes are
‘switched on’ at the 4-cell stage, further embryonic
development stops because of oxidation and fragmen-
tation of the paternal DNA, even after blastocyst
formation [5].
Another recent advance is the demonstration that DNA
integrity is improved after antibiotic treatment in
patients infected with Chlamydia trachomatis [15].
Another recent study demonstrated that, compared
with men without varicocele, men with varicocele have
a higher percentage of sperm cells with DNA fragmenta-
tion. Thus, evaluation of sperm DNA fragmentation
could be an important factor in deciding treatment
options for men with varicocele [9]. This is supported by
further studies, including a small one in which 10 of
11 patients with varicocele showed a significant decrease
in sperm DNA fragmentation after varicocele repair, and
an earlier, larger study of 37 patients [16,17].
Implications for the clinical practice
The evaluation of DNA integrity should be considered
when diagnosing male infertility. However, the different
DNA integrity tests can often draw different conclusions
and sometimes even the same test can yield different
results (most probably due to low study populations),
therefore, interpretations of test results in clinicalpractice
have to be made with some caution. A greater quantity of
larger studies is needed for validation of such tests before
they are ready to be used in general clinical practice.
Despite these limitations, this is an interesting and
promising field that may offer new tools for andrological
diagnostic work-up and may finally lead to more
diagnosis-related instead of symptoms-related treatment
of male infertility.
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